Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M27,930Revenue (TTM) $M2,822Net Margin (%)3.2Altman Z-Score4.2
Enterprise Value $M30,197EPS (TTM) $0.4Operating Margin %21.7Piotroski F-Score6
P/E(ttm)304Beneish M-Score-2.7Pre-tax Margin (%)18.7Higher ROA y-yN
Price/Book3.410-y EBITDA Growth Rate %--Quick Ratio3.1Cash flow > EarningsY
Price/Sales9.95-y EBITDA Growth Rate %35.4Current Ratio3.6Lower Leverage y-yY
Price/Free Cash Flow51.8y-y EBITDA Growth Rate %10.3ROA % (ttm)0.7Higher Current Ratio y-yY
Dividend Yield %--PEG8.8ROE % (ttm)1.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M224ROIC % (ttm)1.2Gross Margin Increase y-yY

Gurus Latest Trades with ALXN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALXNJohn Paulson 2016-06-30 Add0.14%$111.89 - $161.38
($141.84)
$ 124.55-12%Add 70.48%268,000
ALXNJoel Greenblatt 2016-06-30 Add0.07%$111.89 - $161.38
($141.84)
$ 124.55-12%Add 447.16%58,459
ALXNRon Baron 2016-06-30 Add$111.89 - $161.38
($141.84)
$ 124.55-12%Add 11.26%62,249
ALXNDodge & Cox 2016-06-30 Sold Out $111.89 - $161.38
($141.84)
$ 124.55-12%Sold Out0
ALXNJohn Paulson 2016-03-31 Buy 0.17%$127.91 - $190.75
($147.61)
$ 124.55-16%New holding157,200
ALXNJoel Greenblatt 2016-03-31 Buy 0.02%$127.91 - $190.75
($147.61)
$ 124.55-16%New holding10,684
ALXNDodge & Cox 2016-03-31 Buy $127.91 - $190.75
($147.61)
$ 124.55-16%New holding1,820
ALXNRon Baron 2016-03-31 Reduce$127.91 - $190.75
($147.61)
$ 124.55-16%Reduce -8.54%55,950
ALXNRon Baron 2015-12-31 Add0.02%$152.66 - $191.88
($175.28)
$ 124.55-29%Add 87.52%61,177
ALXNDavid Swensen 2015-09-30 Sold Out -16.37%$145.6 - $207.84
($182.41)
$ 124.55-32%Sold Out0
ALXNRon Baron 2015-09-30 Reduce-0.03%$145.6 - $207.84
($182.41)
$ 124.55-32%Reduce -53.24%32,624
ALXNMario Gabelli 2015-09-30 Sold Out $145.6 - $207.84
($182.41)
$ 124.55-32%Sold Out0
ALXNDavid Swensen 2015-06-30 Buy 16.37%$155.01 - $190.92
($172.58)
$ 124.55-28%New holding319,273
ALXNJoel Greenblatt 2015-06-30 Sold Out -0.03%$155.01 - $190.92
($172.58)
$ 124.55-28%Sold Out0
ALXNRon Baron 2015-06-30 Add0.02%$155.01 - $190.92
($172.58)
$ 124.55-28%Add 69.48%69,764
ALXNMario Gabelli 2015-06-30 Buy $155.01 - $190.92
($172.58)
$ 124.55-28%New holding1,415
ALXNJoel Greenblatt 2015-03-31 Reduce-0.09%$171.42 - $189.07
($181.01)
$ 124.55-31%Reduce -72.94%23,261
ALXNRon Baron 2015-03-31 Add0.02%$171.42 - $189.07
($181.01)
$ 124.55-31%Add 124.13%41,163
ALXNJoel Greenblatt 2014-12-31 Add0.13%$159.46 - $200.79
($185.68)
$ 124.55-33%Add 4665.74%85,974
ALXNRon Baron 2014-12-31 Add$159.46 - $200.79
($185.68)
$ 124.55-33%Add 41.92%18,366
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALXN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ALXN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Thiel CarstenEVP, Chief Commercial Officer 2016-09-13Sell3,225$128.67-3.2view
Miller EdwardSVP, Chief Compliance Officer 2016-09-09Sell367$128.32-2.94view
Thiel CarstenEVP, Chief Commercial Officer 2016-09-06Sell1,000$125.94-1.1view
O'Neill JulieEVP. Global Operations 2016-09-02Sell650$126.29-1.38view
Carmichael ClareEVP, Chief HR Officer 2016-08-30Sell1,000$127.76-2.51view
PARVEN ALVIN SDirector 2016-08-22Sell15,700$136.48-8.74view
Wagner Heidi LSVP, Global Government Affairs 2016-08-08Sell222$137.14-9.18view
Sinha VikasEVP & CFO 2016-08-08Sell277$137.14-9.18view
Moriarty John BEVP & General Counsel 2016-08-08Sell135$137.14-9.18view
Carmichael ClareEVP, Chief HR Officer 2016-08-08Sell165$137.14-9.18view

Quarterly/Annual Reports about ALXN:

News about ALXN:

Articles On GuruFocus.com
Spiros Segalas on Alexion Pharmaceuticals Aug 18 2016 
Spiros "Sig" Segalas' Capital Appreciation Fund 2nd Quarter Commentary Aug 18 2016 
Frank Sands Sells Visa, Baidu, Alibaba May 24 2016 
Baron Funds Comments on Alexion Pharmaceuticals May 23 2016 
Baron Funds Comments on Alexion Pharmaceuticals May 23 2016 
Baron Funds Comments on Alexion Pharmaceuticals May 06 2016 
Baron Funds Comments on Alexion Pharmaceuticals Feb 08 2016 
Weekly CFO Sales Highlight: H&R Block, DISH Network, Alexion Pharmaceuticals Jan 03 2016 
Weekly CFO Sells Highlight: Tyson Foods, Alexion Pharmaceuticals, Gilead Sciences Dec 13 2015 
Weekly Insider Sells Highlights: CDW, Twitter, P&G, Alexion Pharmaceuticals Dec 10 2015 

More From Other Websites
Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US :... Sep 26 2016
[$$] Biotech Is Cheaper Than Big Pharma Sep 24 2016
Alexion Gets U.K. Approval for High-Cost Drug (ALXN) Sep 23 2016
Coverage initiated on Alexion Pharma by Wedbush Sep 23 2016
Alexion Employees Volunteer Together in Company’s First Global Day of Service Sep 23 2016
Alexion Employees Volunteer Together in Company’s First Global Day of Service Sep 23 2016
Alexion Employees Volunteer Together in Company’s First Global Day of Service Sep 23 2016
Alexion Employees Volunteer Together in Company’s First Global Day of Service Sep 23 2016
[$$] Biotech Is Cheaper Than Big Pharma: What to Buy Sep 23 2016
ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Sep 22 2016
Alexion Pharmaceuticals: Two Steps Forward, One Step Back Sep 22 2016
UK okays Alexion drug costing up to $2 mln but wants price cut Sep 22 2016
Why Horizon Trades at a Discount Compared to Its Peers Sep 22 2016
UK okays Alexion drug costing up to $2 mln but wants price cut Sep 22 2016
Why Sarepta Approval is Good News for BioMarin, Alexion Sep 20 2016
Biotech bright spots Sep 15 2016
Alexion Pharma (ALXN) Stock Gets 'Underperform' Rating at FBR Capital Sep 15 2016
Alexion’s ‘Uncommon Strength’ Campaign Offers a Win-Win (ALXN) Sep 14 2016
Alexion Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ALXN) : September 14, 2016 Sep 14 2016
Alexion Launches Uncommon Strength Campaign to Unite and Celebrate the Courage and Resilience of... Sep 13 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)